Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00657605 · ClinicalTrials.gov registry record · Phase 2
Effects of Human Leptin Replacement
A Phase 2 study of Obesity and Diabetes, sponsored by University of Miami.
- Completed
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
- 1
- Study location
NCT00657605: Completed Phase 2 study of Obesity and Diabetes, sponsored by University of Miami.
NCT00657605 is a Phase 2 study of Obesity and Diabetes that has completed, run by University of Miami. The registered enrollment target is 3 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00657605, a Phase 2 study of Obesity and Diabetes, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the hypothesis that leptin contributes to the regulation of the dynamics of human endocrine function.
Conditions Studied
Interventions
- DRUG Recombinant methionyl human leptin
Study Locations (1)
Florida
- University of Miami Miller School of Medicine, Center on Pharmacogenomics - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2001-06 |
| Est. Completion | 2010-05-04 |
| Phase | Phase 2 |
What the finished NCT00657605 record still lists
NCT00657605 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Recombinant methionyl human leptin is the first listed.
NCT00657605 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00657605 about?
NCT00657605 is a clinical study titled "Effects of Human Leptin Replacement". This study will test the hypothesis that leptin contributes to the regulation of the dynamics of human endocrine function.
What is the current status of trial NCT00657605?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2001-06. Estimated completion is 2010-05-04.
What conditions does trial NCT00657605 study?
This clinical trial studies the following conditions: Obesity, Diabetes, Metabolic Syndrome.
What interventions are being tested in trial NCT00657605?
The interventions under investigation include: Recombinant methionyl human leptin (DRUG).
Who is sponsoring clinical trial NCT00657605?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00657605 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00657605's enrollment target sits among peer trials
3 1054th of 1053 the lowest of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Convergent Mechanisms Underlying Reprometabolic Syndrome in Women
RECRUITING · Phase 2
-
Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity
RECRUITING · Phase 2
-
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RECRUITING · Phase 2
-
Pharmacological and Behavioral Treatment After Bariatric Surgery
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia